Dr. Shah is a Consultant in Hematology and BMT at Mayo Clinic, Rochester. He sees patients with myeloid neoplasms and those undergoing CAR-T or BMT.

Prior to joining Mayo Clinic, he received his PhD in Molecular Medicine at Penn State Hershey Medical Center followed by training in Internal Medicine at the same hospital. He did his Hematology/Oncology fellowship at Mayo Clinic Rochester and a Fellowship in Stem Cell Transplant and Cellular Therapy at M.D. Anderson Cancer Center.

His research focuses on prediction, prevention, and treatment of therapy-related myeloid neoplasms.